RecruitingNANCT07509827

Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)

Sponsor: Institute of HIV Research and Innovation Foundation, Thailand

Trial Details

Condition	HIV Prevention, HIV Related Stigma, PrEP Adherence
Intervention	Mobile Healthy Choices (mHC)+SPC; FRESH + SPC; mHC + FRESH + SPC
Phase	NA
Status	Recruiting
Participants	108
Est. Completion	31 July 2027
Last Updated	3 Apr 2026

Primary Outcome

HIV-related stigma score; PrEP uptake; PrEP adherence; HIV testing uptake

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Age 18-29 years * Male sex at birth * Self-identify as transgender woman/female spectrum * HIV-negative (laboratory confirmed) * Recent condomless sex * Able to understand Thai * Not on PrEP or poorly adherent (≤3 pills/week) Exclusion Criteria: * Serious cognitive or psychiatric condition affecting consent * Active suicidal ideation or major mental illness * Medical contraindications to PrEP * Enrolled in another HIV intervention study

Trial Sites

Countries

Thailand

View Registry Entry

Related Analysis

Novel mHealth Intervention Targets HIV Prevention and Stigma Among Transgender Women — EMPOW.HER Trial Opens in Thailand

The EMPOW.HER trial in Thailand is testing innovative mobile health interventions to reduce HIV-related stigma and improve PrEP uptake among young transgender women. This groundbreaking study combines digital platforms targeting both prevention education and stigma reduction in a population facing disproportionate HIV risks.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service